{"data": [{"news_url": "https://www.investors.com/news/technology/mrna-stock-dives-public-offering-despite-coronavirus-efforts/", "image_url": "https://cdn.snapi.dev/images/v1/r/f/rfvw1wfgg-2.jpg", "title": "How A Two-Day Plunge Wiped Out This Biotech's Coronavirus Gains", "text": "Moderna announced the pricing of its secondary offering Wednesday, sending MRNA stock into a two-day dive that wiped out gains from last week related to its coronavirus vaccine efforts.", "source_name": "Investors Business Daily", "date": "Wed, 12 Feb 2020 13:24:06 -0500", "topics": [], "sentiment": "Negative", "type": "Article", "tickers": ["MRNA"]}, {"news_url": "https://www.fool.com/investing/2020/02/12/heres-why-moderna-slipped-lower-today.aspx", "image_url": "https://cdn.snapi.dev/images/v1/b/y/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5577212fbalance-sheetjpgw700opresize.jpg", "title": "Here's Why Moderna Slipped Lower Today", "text": "A secondary offering causes dilution for the biotech.", "source_name": "The Motley Fool", "date": "Wed, 12 Feb 2020 13:12:00 -0500", "topics": [], "sentiment": "Negative", "type": "Article", "tickers": ["MRNA"]}, {"news_url": "https://www.fool.com/investing/2020/02/12/is-moderna-a-buy.aspx", "image_url": "https://cdn.snapi.dev/images/v1/a/i/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5572482fgettyimages-1139071824jpgw700opresize.jpg", "title": "Is Moderna a Buy?", "text": "This mRNA vaccine developer has become a hot stock due to the coronavirus epidemic.", "source_name": "The Motley Fool", "date": "Wed, 12 Feb 2020 09:30:00 -0500", "topics": [], "sentiment": "Neutral", "type": "Article", "tickers": ["MRNA"]}]}